Targeting SARS-CoV-2 proteases and polymerase for COVID-19 treatment: state of the art and future opportunities
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.
R Cannalire, C Cerchia, AR Beccari… - Journal of Medicinal …, 2020 - europepmc.org
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
[HTML][HTML] Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
R Cannalire, C Cerchia, AR Beccari… - Journal of Medicinal …, 2022 - ncbi.nlm.nih.gov
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
[PDF][PDF] Targeting SARS-CoV‑2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
R Cannalire, C Cerchia, AR Beccari, FS Di Leva… - researchgate.net
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
[引用][C] Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
R Cannalire, C Cerchia, AR Beccari… - Journal of Medicinal …, 2020 - cir.nii.ac.jp
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art
and Future Opportunities | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
and Future Opportunities | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
R Cannalire, C Cerchia, AR Beccari… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
R Cannalire, C Cerchia, AR Beccari… - JOURNAL OF …, 2020 - iris.unina.it
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.
R Cannalire, C Cerchia, AR Beccari… - Journal of Medicinal …, 2020 - europepmc.org
The newly emerged coronavirus, called SARS-CoV-2, is the causing pathogen of pandemic
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …
COVID-19. The identification of drugs to treat COVID-19 and other coronavirus diseases is …